Differential gene expression in human granulosa cells from recombinant FSH versus human menopausal gonadotropin ovarian stimulation protocols

Differential gene expression in human granulosa cells from recombinant FSH versus human menopausal gonadotropin ovarian stimulation protocols

BACKGROUND The study was designed to test the hypothesis that granulosa cell (GC) gene expression response differs between recombinant FSH and human menopausal gonadotropin (hMG) stimulation regimens. METHODS Females < 35 years-old undergoing IVF for tubal or male factor infertility were prospectively randomized to one of two stimulation protocols, GnRH agonist long protocol plus individualiz...

Human Menopausal Gonadotropin versus Recombinant FSH in Polycystic Ovary Syndrome Patients Undergoing In Vitro Fertilization

human menopausal gonadotropin versus recombinant fsh in polycystic ovary syndrome patients undergoing in vitro fertilization

0

Human Menopausal Gonadotropin versus Recombinant FSH in Polycystic Ovary Syndrome Patients Undergoing In Vitro Fertilization

BACKGROUND We aimed to compare human menopausal gonadotropin (hMG) and recombinant follicle-stimulating hormone (r FSH) with respect to clinical outcomes and the development of ovarian hyperstimulation syndrome (OHSS) for patients with polycystic ovary syndrome (PCOS) treated with in vitro fertilization (IVF). MATERIALS AND METHODS This prospective randomized controlled trial included a total...

effects of human menopausal gonadotropin on zona pellucida and pregnancy outcomes of ovarian stimulation protocols

background: human menopausal gonadotropin (hmg) has contributed many improvements to human assisted reproduction. however, effects of hmg on oocyte development and clinical results remain controversial. objective: this study was conducted to investigate the effects of hmg on the zona pellucida of oocytes, as well as clinical results in superovulation treatment. materials and methods: this retro...